Scleritis and Intraorbital Inflammation following Oral and Intravenous Bisphosphonates in a 66-Year-Old Man

Katharina Heck,Svetlana Malinina,Anja Palmowski
DOI: https://doi.org/10.1055/a-2229-2946
2024-04-25
Klinische Monatsblätter für Augenheilkunde
Abstract:A recent review has identified 101 reports of bisphosphonate-associated ocular inflammations such as uveitis, scleritis, episcleritis, orbital inflammation, and/or conjunctivitis [1]. In view of the widespread use of these medications to treat osteoporosis, it is important to alert ophthalmologists to these rare ocular manifestations. Therefore, we present a 66-year-old man who developed posterior scleritis and intraorbital inflammation following bisphosphonate treatment for osteoporosis. Received: 28 September 2023 Accepted: 12 December 2023 Article published online: 23 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
ophthalmology
What problem does this paper attempt to address?